arXiv subjects

Ruiheng Yu

Publications and source records attributed to Ruiheng Yu.

4 recordsLinked to original sources

arXiv2026

Treatment Response Optimized Clinical Decision Support AI System via Digital Twin Simulation

Clinical decision support AI systems (CDSASs) must adapt to evolving patient conditions in real-time while adhering to strict safety constraints. We present an online adaptive framework that integrates Treatment Effect (TE) estimation to quantify clinical benefits, a patient Digital Twin (DT) to simulate treatment trajectories, and Reinforcement Learning (RL) for sequential decision-making. The AI system is initially trained on historical medical records and operates in a continuous learning loop. To ensure safety, a rule-based module monitors vital signs and blocks contraindicated treatments. Cases with strong internal model disagreement are flagged for clinician review, simulated in our experiments via a pre-trained outcome model. We validate our framework using both a synthetic clinical simulator and a real-world ovarian cancer dataset from The Cancer Genome Atlas (TCGA). In both simulated and clinical settings, our method demonstrated superior effectiveness and stability in recommending treatments compared to standard computational baselines. Furthermore, the AI system maintains low latency and requires expert consultation for only a minority of cases in our experimental validation, demonstrating its potential as a safe, clinician-supervised tool for personalized medicine that continuously improves through practical use.

cs.AI↗

arXiv2026

Can Physician Expertise Improve Machine Learning Identification of Delirium?

Delirium is common in hospitalized patients and is often missed in routine care. We present a user-centered interactive machine learning (UC-iML) framework for delirium detection support that combines physician-guided feature refinement with interpretable modeling. Using 3,862 labeled admissions from six Toronto hospitals in the General Medicine Inpatient Initiative (GEMINI), we integrate administrative variables, laboratory results, medications, and a radiology-derived text indicator. Physicians guide feature refinement and model evaluation, and Shapley Additive exPlanations (SHAP) are used to summarize feature attribution. We evaluate standard supervised classifiers with temporally separated holdout testing and a later-phase validation cohort. Compared with automated and baseline variants, the proposed framework shows better overall discrimination and stronger temporal robustness, while the explanations highlight clinically meaningful signals. These results support UC-iML as a practical human-in-the-loop framework for clinically relevant delirium modeling.

cs.CY↗

arXiv2026

Estimating Treatment Effects for Depression in Longitudinal Therapy Switching Settings

Depression treatment often requires switching medications due to inadequate response or adverse effects. Estimating individualized treatment effects in this setting is challenging because treatment assignment is confounded by patient characteristics, switching induces time-varying selection, and counterfactual outcomes are not observed in follow-up data. Using a proprietary longitudinal major depressive disorder (MDD) clinical trial dataset, we formulate a next-visit counterfactual prediction task to estimate Hamilton Depression Rating Scale (HAMD-17) total scores under alternative treatments. We benchmark 8 estimators, including meta-learners, residual-based methods, and tree-based approaches. Causal Forest (CF) demonstrates the most favorable and consistent performance across all criteria. Our analysis shows that symptom benefits concentrate in specific switch directions, with dose intensification being generally beneficial. Notably, we identify a counterintuitive exception where a lower-intensity regimen outperforms a higher-intensity alternative for specific patient subsets. While crude observational comparisons substantially overstate gains, confounding-adjusted estimates yield modest, actionable magnitudes. These findings provide prospectively testable candidates for clinical decision support in depression care.

stat.AP↗

arXiv2025

Reinforcement Learning enhanced Online Adaptive Clinical Decision Support via Digital Twin powered Policy and Treatment Effect optimized Reward

Clinical decision support must adapt online under safety constraints. We present an online adaptive tool where reinforcement learning provides the policy, a patient digital twin provides the environment, and treatment effect defines the reward. The system initializes a batch-constrained policy from retrospective data and then runs a streaming loop that selects actions, checks safety, and queries experts only when uncertainty is high. Uncertainty comes from a compact ensemble of five Q-networks via the coefficient of variation of action values with a $\tanh$ compression. The digital twin updates the patient state with a bounded residual rule. The outcome model estimates immediate clinical effect, and the reward is the treatment effect relative to a conservative reference with a fixed z-score normalization from the training split. Online updates operate on recent data with short runs and exponential moving averages. A rule-based safety gate enforces vital ranges and contraindications before any action is applied. Experiments in a synthetic clinical simulator show low latency, stable throughput, a low expert query rate at fixed safety, and improved return against standard value-based baselines. The design turns an offline policy into a continuous, clinician-supervised system with clear controls and fast adaptation.

cs.AI↗